On January 3, 2018 INSYS Therapeutics, Inc. (NASDAQ:INSY), reported that Saeed Motahari, president and chief executive officer, and Andrew Long, chief financial officer, will present at the 36th annual J.P. Morgan Healthcare Conference as follows(Press release, Insys Therapeutics, JAN 3, 2018, View Source;p=RssLanding&cat=news&id=2324652 [SID1234522833]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Date: Thursday, Jan. 11, 2018
Time: 7:30 a.m. Pacific Standard Time
Location: San Francisco – Westin St. Francis Hotel
The presentation will be webcast live at the aforementioned time, and archived for 30 days thereafter, via the Investors section of company’s website at View Source, under Presentations & Events. The presentation slides will be available during the conference, accessible at the same webpage.

In addition to making a presentation, management will also provide an overview of the company’s business in one-on-one meetings with investors who are registered to attend the conference.

On January 3, 2018 Celgene Corporation (NASDAQ: CELG) reported that it will host a conference call and live audio webcast on Thursday, January 25, 2018 at 9 a.m. ET to discuss fourth quarter and full-year 2017 financial and operational results (Press release, Celgene, JAN 3, 2018, View Source [SID1234522832]). The webcast can be accessed from the Investor Relations page at www.celgene.com.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

On January 3, 2018 BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) reported that executives from the Company are scheduled to provide a corporate summary and update regarding the Company’s clinical programs at the 36th annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 10, 2018 at 3:30 p.m. Pacific Time (Press release, BioCryst Pharmaceuticalsa, JAN 3, 2018, View Source [SID1234522831]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Links to a live audio webcast and replay of the presentation may be accessed on the BioCryst website events page at View Source

On January 3, 2018 Emergent BioSolutions Inc. (NYSE:EBS) reported that a member of the company’s senior management team will participate in the following investor conferences during the first quarter of 2018 (Press release, Emergent BioSolutions, JAN 3, 2018, View Source;p=RssLanding&cat=news&id=2324588 [SID1234522827]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

J.P. Morgan & Co. – 36th Annual Healthcare Conference
San Francisco, CA
January 8-11, 2018

RBC Capital Markets – 2018 Global Healthcare Conference
New York, NY
February 21-22, 2018

Cowen & Co. – 38th Annual Health Care Conference
Boston, MA
March 12-14, 2018
Presentation dates and times will be updated on the Emergent website www.emergentbiosolutions.com under "Investors" as the information becomes available.

For these conferences, the company will be webcasting its presentation, which may include a discussion of the company’s recent business developments as well as its most recently reported financial results and guidance. The webcasts will be available both live and by replay, accessible from the Emergent website.

On January 3, 2018 Nektar Therapeutics (Nasdaq: NKTR) reported that it’s President and Chief Executive Officer, Howard Robin, is scheduled to present at the upcoming 36th Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 9, 2018 at 11:00 a.m. Pacific Time (Press release, Nektar Therapeutics, JAN 3, 2018, View Source [SID1234522829]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The presentation will be accessible via a Webcast through a link posted on the Investors, Events Calendar section of the Nektar website: View Source In addition, the company will webcast the Q&A breakout session immediately following its presentation at 11:30 a.m. Pacific Time. This Webcast will be available for replay until February 20, 2018.